Abstract

Disclosed is an extract of algae of the order Ulvales, including sulfated and non-sulfated polyanionic polysaccharides, the molecular weight of which is less than or equal to 50 kDa, for use in the prevention and/or treatment of complications caused by post-traumatic immunosuppression.

IPC Classes  ?

• A61K 36/05 - Chlorophycota or chlorophyta (green algae), e.g. Chlorella
• A61P 37/02 - Immunomodulators

Abstract

The present invention relates to an algal extract comprising sulphated and non-sulphated polyanionic polysaccharides, to a method for preparing an algal extract as well as to its therapeutic and prophylactic applications.

IPC Classes  ?

• A61K 36/09 - Lichens
• A61K 36/05 - Chlorophycota or chlorophyta (green algae), e.g. Chlorella
• A61K 31/737 - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

Abstract

The present invention relates to an extract of algae of the order Ulvales, comprising sulfated and non-sulfated polyanionic polysaccharides, the molecular weight of which is less than or equal to 50 kDa, for use in the prevention and/or treatment of complications caused by post-traumatic immunosuppression.

IPC Classes  ?

• A61K 36/05 - Chlorophycota or chlorophyta (green algae), e.g. Chlorella
• A61P 37/04 - Immunostimulants
• A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Abstract

The present invention relates to an extract of algae of the order Ulvales, comprising sulfated and non-sulfated polyanionic polysaccharides, the molecular weight of which is less than or equal to 50 kDa, for use in the prevention and/or treatment of complications caused by post-traumatic immunosuppression.

IPC Classes  ?

• A61K 36/05 - Chlorophycota or chlorophyta (green algae), e.g. Chlorella
• A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
• A61P 37/04 - Immunostimulants

Abstract

The present invention relates to an algal extract comprising sulphated and non-sulphated polyanionic polysaccharides, to a method for preparing an algal extract as well as to its therapeutic and prophylactic applications.

IPC Classes  ?

• A01N 65/00 - Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
• A61K 36/05 - Chlorophycota or chlorophyta (green algae), e.g. Chlorella
• A61K 31/737 - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

Abstract

Ulva type for modulating the immune response.

IPC Classes  ?

• A61K 36/05 - Chlorophycota or chlorophyta (green algae), e.g. Chlorella
• A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
• A61K 39/00 - Medicinal preparations containing antigens or antibodies

Abstract

The invention relates to an extract of algae of the order Ulvales, in particular an extract of Ulva-type green algae, for use in order to modulate immune response in humans or animals, and in particular to stimulate immune response to infections. The invention also relates to the non-therapeutic use of an extract of Ulva-type green algae in order to modulate immune response.

IPC Classes  ?

• A61K 36/05 - Chlorophycota or chlorophyta (green algae), e.g. Chlorella
• A61P 37/02 - Immunomodulators

Abstract

The invention relates to an extract of algae of the order Ulvales, in particular an extract of Ulva-type green algae for use in the prevention and/or treatment of a bacterial infection.

IPC Classes  ?

• A61K 36/05 - Chlorophycota or chlorophyta (green algae), e.g. Chlorella
• A61P 31/04 - Antibacterial agents

Abstract

The present invention relates to an algal extract comprising sulphated and non-sulphated polyanionic polysaccharides, to a method for preparing an algal extract, and also to the therapeutic and prophylactic uses thereof.

IPC Classes  ?

• A61K 36/05 - Chlorophycota or chlorophyta (green algae), e.g. Chlorella
• A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia